Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemoglobin Beta Thalassemia”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06490601
What this trial is testing

Long Term Beta Thalassemia Treatment: Findings From The Extension Period

Who this might be right for
Fetal HemoglobinBeta-ThalassemiaHemoglobinopathies
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 30
Testing effectiveness (Phase 2)Looking for participantsNCT05735717
What this trial is testing

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaRemission+21 more
Masonic Cancer Center, University of Minnesota 70
Not applicableStudy completedNCT04691323
What this trial is testing

The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.

Who this might be right for
Sickle Cell DiseaseSickle B+ ThalassemiaSickle Beta Zero Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago 68
Not applicableStudy completedNCT04675645
What this trial is testing

Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App

Who this might be right for
Sickle Cell DiseaseSickle B+ ThalassemiaSickle Beta Zero Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago 33
Testing effectiveness (Phase 2)Study completedNCT00153985
What this trial is testing

Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies

Who this might be right for
HemoglobinopathiesSickle Cell DiseaseThalassemia
Dana-Farber Cancer Institute 2
Post-approval studies (Phase 4)Study completedNCT06606886
What this trial is testing

Effects of Hydroxyurea and Metformin in Transfusion Dependent Beta-Thalassemia

Who this might be right for
Transfusion Dependent Beta-thalassemia
Bahria University 96
Not applicableStudy completedNCT01715480
What this trial is testing

Effect of Broccoli Sprouts Homogenate on SS RBC

Who this might be right for
Sickle Red Blood CellFetal HemoglobinOxidative Stress
Duke University 21
Not applicableStudy completedNCT02326597
What this trial is testing

Decision Aid for Therapeutic Options In Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell AnemiaHemoglobin SS+2 more
Emory University 134
Testing effectiveness (Phase 2)Study completedNCT04987489
What this trial is testing

Etavopivat in Patients With Thalassemia or Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseThalassemia
Forma Therapeutics, Inc. 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT06308159
What this trial is testing

An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia

Who this might be right for
Beta-Thalassemia
Lantu Biopharma 6
Early research (Phase 1)Study completedNCT00005783
What this trial is testing

A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders

Who this might be right for
Hemoglobin SC DiseaseSickle Cell Anemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Testing effectiveness (Phase 2)Study completedNCT03877809
What this trial is testing

Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients

Who this might be right for
Beta-Thalassemia
Rare Partners srl Impresa Sociale 26
Testing effectiveness (Phase 2)Study completedNCT03763656
What this trial is testing

Pharmacokinetics of Oral Hydroxyurea Solution

Who this might be right for
Sickle Cell DiseaseSickle-Cell; Hemoglobin Disease, ThalassemiaSickle Cell-beta-thalassemia+1 more
Nova Laboratories Limited 33
Not applicableStudy completedNCT07486531
What this trial is testing

Iron Accumulation in Erythrocytes in Patients

Who this might be right for
Beta Thalassemia Major
Ankara City Hospital Bilkent 100
Testing effectiveness (Phase 2)UnknownNCT03276455
What this trial is testing

Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified

Who this might be right for
Beta Thalassemia Major
Nanfang Hospital, Southern Medical University 10
Testing effectiveness (Phase 2)Study completedNCT00005934
What this trial is testing

5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia

Who this might be right for
Beta Thalassemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Not applicableStudy completedNCT04802629
What this trial is testing

Fetal Haemoglobin and Cerebral and Peripheral Oxygenation.

Who this might be right for
Preterm BirthOxygen ToxicityFetal Hemoglobin
Medical University of Graz 50
Not applicableLooking for participantsNCT07672275
What this trial is testing

Transfusion-Related Changes in Oxidative Stress Biomarkers in Neonates

Who this might be right for
Oxidative Stress in NeonatesNear Infrared SpectroscopyFetal Hemoglobin+1 more
Medical University of Graz 170
Testing effectiveness (Phase 2)Study completedNCT00790127
What this trial is testing

Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia

Who this might be right for
Beta Thalassemia
HemaQuest Pharmaceuticals Inc. 21
Testing effectiveness (Phase 2)Study completedNCT01745120
What this trial is testing

A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in β-Thalassemia Major Participants

Who this might be right for
β-thalassemia Major
Genetix Biotherapeutics Inc. 19
Next Page